AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Can AI help in Drug Development ?
This is the talk given by Innoplexus Co-founder & CTO, Mr. Gaurav Tripathi at DataHack 2018 – an event by Analytics Vidhya.
Lot of analytics companies from silicon valley to budding startups are targeting to solve the problem of drug discovery to suggesting prescriptions. But would you really trust a cancer medicine suggested by a software program?
AI today is at a level of doing lower cognitive tasks such as aggregating numbers, finding patterns, suggesting correlations rather than understanding human level intelligence of thoughts, implications or emotions. That is why it should be used to solve the time-consuming and mundane problems leaving the quick and theoretically complex decisions to the judgement of the experts such as doctors, making it win-win for everyone.
Here, Gaurav would talk about three AI technologies Innoplexus has developed to cut down drug development time at all stages and how should one pursue the field to facilitate traditional institutions for patient care.
Evolutionary learning based Incremental crawling
Computer vision based information comprehension
Ontology-based life sciences language processing
This video originally published on youtube channel of Analytics Vidhya.
AI supports targeted therapy recommendations fortumor diseases – BMBF funds
The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary…
OncoCoin AG donates for a charity bicycle tour: Tour of
Bad Hersfeld / Germany, Aug 02, 2022– Mayor Thomas Fehling took the opportunity at the Smart City Forum, which took…
Innoplexus and Innovatrix capital partner to bring about new risk-transfer
Artificial Intelligence (AI) pioneer Innoplexus and London based Parametric Insurance start-up, Innovatrix Capital, collaborating upon using AI & Machine Learning…
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence to expedite PIM kinase inhibitor development ESCHBORN, Germany, May 30,…
Innoplexus and Parexel Expand Capabilities of COVID-19 Information Platform
COVID-19 Clearinghouse is the go-to platform for directly accessing the latest information and research about the coronavirus and COVID-19. ESCHBORN, Germany, Boston,…
Parexel and Innoplexus Unveil Single Source of COVID-19 Information for
COVID-19 Clearinghouse enables direct access to latest COVID-19 datasets, publications, research and clinical trials BOSTON and DURHAM, N.C. and ESCHBORN, Germany,…